Skip to main content

Platelet Activity in Relation to Smoke and Exercise in Patients with Chronic Obstructive Lung Disease: Effects of Platelet Antiaggregating Drugs

  • Chapter
Thrombosis and Cardiovascular Disease

Abstract

Lung tissue is involved in the synthesis and/or metabolism of many vasoactive substances such as histamine, serotonin, dopamine, norepinephrine, bradikinin, angiotensin II and prostaglandins (1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Y. Bakhle, J.R. Vane, Metabolic function of the lungs. In: Marcel Dekker, Inc., New York and Basel, 1977.

    Google Scholar 

  2. S.M.M. Karim, P.G. Adaikan, S.R. Cottegoda, Prostaglandins and human respiratory smooth muscle: structure-activity relationship. In: Advances in prostaglandins and thromboxane research, Vol. 7, edited by Samuelsson B., Romvell P.W. and Paoletti R., Raven Press, New York, p. 969, 1980.

    Google Scholar 

  3. P.I. Kadowitz, E.W. Spannhake, J.L. Levin, A.L. Hyman, Differential actions of prostaglandins and the pulmonary vascular bed. In: Advances in prostaglandins and thromboxane research, Vol. 7, edited by Samuelsson B., Romvell P.W. and Paoletti R., Raven Press, New York, p. 731, 1980.

    Google Scholar 

  4. A.P. Smith, Advances in prostaglandin research. Practical applications of prostaglandins and their synthesis inhibitors, edited by S.M.M. Karim, M.T.P. Press Ltd, Lancaster, 83, 1976.

    Google Scholar 

  5. P.J. Kadowitz, A.L. Hyman, Vasoconstrictor effects of thromboxane B2 on the canine and feline pulmonary bed. In press.

    Google Scholar 

  6. R.J. Gryglewski, R. Korbutt, A. Ocetkiewicz, Generation of prostacyclin by the lungs in vivo and its release into the arterial circulation. Nature 273:765 (1978).

    Article  PubMed  CAS  Google Scholar 

  7. R.J. Gryglewski, Is the lung an endocrine organ that secretes prostacyclin. In: Prostacyclin, edited by J.R. Vane and S. Bergstrom, Raven Press, New York, p.275, 1979.

    Google Scholar 

  8. A. Musca, C. Cordova, F. Violi, A. Perrone, C. Alessandri, F. Pavone, F. Balsano, Fibrin polymerization behaviour in patients with chronic respiratory failure. In: (Abstract), VIII European Congress of Cardiology, Paris, June 22–26, 1980.

    Google Scholar 

  9. A. Paunesco-Podeanu, C. Bratu, T. Tarachiu, M. Cotsecu, V. Bratu, A. Bucur, Les thromboses pulmonaires qui compliquent l’insuffisance respiratoire et le coeur pulmonaire chronique. Med. Int. (Buc.) 25:473 (1973).

    Google Scholar 

  10. F. Balsano, C. Cordova, A. Musca, A. Perrone, F. Violi, Metabolismo polmonare ed emocoagulazione in fisiologia, patologia e clinica. Clin. Ter. 80:513 (1977).

    PubMed  CAS  Google Scholar 

  11. P. Steel, H.R. Ellis, S. Weily, E. Genton, Platelet survival time in patients with hypoxemia and pulmonary hypertension. Circulation 55:660 (1977).

    Article  Google Scholar 

  12. R. Breda, B. Bizzi, R. Landolfi, Ruolo del polmone nell’emocoagulazione. Clin. Ter. 94 (Suppl. 1), 1, 41 (1980).

    Google Scholar 

  13. E. Tremoli, L. Bertoli, P. Maderna, F. Conti, R. Marlini, O. Mantero, Platelet antiaggregating therapy in chronic obstructive lung disease. Clin. Resp. Physiol. 16:84 (1980).

    Google Scholar 

  14. C. Cordova, A. Musca, F. Violi, G.C. De Mattia, A. Perrone, C. Alessandri, F. Balsano, Plasma beta-thromboglobulin levels in patients with chronic respiratory failure. In: Abstracts. VIII European Congress of Cardiology, Paris, June 22–26, 1980.

    Google Scholar 

  15. D.A. Rickaby, C.A. Dawson, M.B. Maron, Pulmonary inactivation of serotonin and site of serotonin pulmonary vasoconstriction. J. Appl. Physiol. 48:606 (1980).

    PubMed  CAS  Google Scholar 

  16. J. Svensson, T. Strandberg, T. Tuveno, M. Hamberg, Thromboxane A2: effects on airway and vascular smooth muscle. Prostaglandins 14:426 (1977).

    Google Scholar 

  17. J.D. Dusting, S. Moncada, J. Vane, Prostaglandins, their intermediates and precursors: cardiovascular actions and regulatory role in normal and abnormal circulatory system. Progr. Cardiovasc. Dis. 21:405 (1979).

    Article  CAS  Google Scholar 

  18. J.C. Frölich M. Ogletree, B.A. Peskar, K.L. Brigham, Pulmonary hypertension correlated to pulmonary thromboxane synthesis. In: Advances in prostaglandin and thromboxane research, Vol. 7, edited by Samuelsson P., Romwell P.W. and Paoletti R., Raven Press, New York, p. 745, 1980.

    Google Scholar 

  19. K. Radegran, S.E. Bergentz, D.H. Lewis, U. Ljungquist, P. Olsson, Pulmonary effects of induced platelet aggregation. Intravascular obstruction or vasoconstriction? Scand. J. Clin. Lab. Invest. 28:423 (1971).

    Article  PubMed  CAS  Google Scholar 

  20. G. Bo, J. Hognestad, Effects on the pulmonary circulation of suddenly induced intravascular aggregation of blood platelets. Acta Physiol. Scand. 85:523 (1972).

    Article  PubMed  CAS  Google Scholar 

  21. S. Moncada, R. Corbutt, Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet 1:1268 (1978).

    Google Scholar 

  22. K.A. Jorgensen, J. Dyeberg, E. Stoffersen, Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation. Pharm. Res. Commun. 11:605 (1979).

    Article  CAS  Google Scholar 

  23. K.E. Blass, H.U. Block, W. Förster, K. Ponicke, Dipyridamole, a potent stimulator of prostacyclin (PGI2) biosynthesis. Br. J. Pharmacol. 68:71 (1980).

    Article  PubMed  CAS  Google Scholar 

  24. G.G. Neri Serneri, G. Masotti, L. Poggesi, G. Galanti, S. Castellani, Dipyridamole stimulates prostacyclin biosynthesis in man and in vitro. In: 6th International Congress on Thrombosis, Montecarlo, October 23–25, 1980.

    Google Scholar 

  25. G.G. Neri Serneri, G. Masotti, R. Abbate, S. Fabula, L. Poggesi, G.F. Gensini, G. Galanti, R. Laureano, Enhanced prostacyclin production and decreased thromboxane formation by dipyridamole. In: Florence International Meeting on Myocardial Infarction, Experta Medica, Vol. I, p.489, 1979.

    Google Scholar 

  26. G. Masotti, G. Galanti, L. Poggesi, R. Abbate, G.G. Neri Serneri, Differential inhibition of PGI2 production and platelet aggregation by aspirin in humans. In: 5th International Congress on Thromboembolism, Bologna May 29-June 2 (Abstract) p.46, 1978.

    Google Scholar 

  27. G. Masotti, R. Abbate, G. Galanti, L. Poggesi, G.G. Neri Serneri, Are conventional doses of acetylsalicyclic acid advisable in prevention of thrombosis? In: Florence International Meetings on Myocardial Infarction, Experta Medica, Vol. I, p.489, 1979.

    Google Scholar 

  28. C.A. Ludlam, B. Moores, A. Boctona, D.S. Pepper, J.D. Cash, The release of a human platelet specific protein measured by radioimmunoassay. Thromb. Res. 6:543 (1975).

    Article  PubMed  CAS  Google Scholar 

  29. R.J. Lewy, J.B. Smith, M.J. Silver, J. Saia, P. Walinsky, L. Weiner, Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal angina. Prostaglandins Med. 42:425 (1979).

    Google Scholar 

  30. J.A. Salmon, A radioimmunoassay for 6-keto PGF. Prostaglandins 3:383 (1978).

    Google Scholar 

  31. J.A. Nadel, J.H. Comore, Acute effect of inhalation of cigarette smoke on airway conductance. J. Appl. Physiol. 16:713 (1961).

    PubMed  CAS  Google Scholar 

  32. G.M. Starling, Mechanism of bronchoconstriction caused by cigarette smoking. Br. Med. J. 3:275 (1967).

    Article  Google Scholar 

  33. J.M. Miller, B.J. Sproule, Acute effects of inhalation of cigarette smoke on mechanical properties of the lungs. Am. Rev. Resp. Dis. 94:721 (1966).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Novo, S. et al. (1984). Platelet Activity in Relation to Smoke and Exercise in Patients with Chronic Obstructive Lung Disease: Effects of Platelet Antiaggregating Drugs. In: Strano, A. (eds) Thrombosis and Cardiovascular Disease. Advances in Experimental Medicine and Biology, vol 164. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8616-2_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8616-2_34

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8618-6

  • Online ISBN: 978-1-4684-8616-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics